Virbac SA

€359.50As of Sun 8 Nov 2026, 12:00 UTC
EPA:VIRPHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR 9.74%
Div yield 0.40%
ROE 13.61%
Drug Manufacturers (General)
Beta (5Y) 0.75
PE TTM 19.35
TSR TTM 1.86%
Mkt cap €3.013B
ROIC 11.69%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€385
6.96%
221.24%
Hold 9|3|1|11|12
4Q25
1Q26
2Q26
3Q26
Earnings per share€
5.20
5.62
5.38
5.85
17.55%
26.30%
14.41%
25.25%
Revenue€M
204.2
215.2
221.1
221.8
(3.56%)
4.27%
9.12%
12.71%
Peers (US$3.383B)
Cap (US$)
PE
14.61B
25.72x
1.154B
16.23x
388.0M
13.19x
3.643B
17.14x
Capital
TTM
5Y
10Y
Leveragex
6.351
1.376
0.992
EBIT/Intx
1.034
0.911
0.814
Own earn%
8.31
62.79
56.76
Sh yield%
33.57
18.78
19.70
Owners
Insiders/Inst%
9.80
76.82
Short interest%
2.79
SBC / revenue%
2.18
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
1–8
$1 testx
—
Incr. ROIC%
2